缬沙坦和冬虫夏草制剂联合治疗2型糖尿病肾病的疗效分析(1)
 |
| 第1页 |
参见附件。
[摘要] 目的 探讨缬沙坦和冬虫夏草制剂联合治疗2型糖尿病肾病的疗效。 方法 随机选取在本院治疗的2型糖尿病肾病患者80例分为对照组和观察组。对照组(40例)服用缬沙坦，观察组(40例)在此基础上加用冬虫夏草制剂。治疗后对比两组患者治疗前后的血尿检查和临床疗效。 结果 观察组24 h尿微量清蛋白排泄率(UAE)显著下降，与对照组相比，差异有统计学意义，P < 0.05；观察组疗效高于对照组，P < 0.05。 结论 缬沙坦和冬虫夏草制剂联合使用可降低2型糖尿病肾病患者的蛋白尿水平。
[关键词] 糖尿病肾病；缬沙坦；冬虫夏草制剂；疗效分析
[中图分类号] R587.2 [文献标识码] A [文章编号] 1674—4721(2012)09(c)—0071—02
Effect analysis of valsartan and cordyceps preparation in the treatment of type 2 diabetic nephropathy
WU Weiting
The First Department of Internal， People''s Hospital of Puning City in Guangdong Province， Puning 515300， China
[Abstract] Objective To explore the clinic effect of valsartan and cordyceps preparation in the treatment of type 2 diabetic nephropathy. Methods Eighty cases of type 2 diabetic nephropathy patients treated in our hospital were randomly selected and divided into the control group and the observation group. The control group (n = 40) took valsartan， the observation group (n = 40) used cordyceps preparation based on the control group. The blood and urine examination and clinic effect of two groups were compared. Results UAE of the observation group decreased significantly， compared with the control group， the differences had statistically significant (P < 0.05)； The therapeutical effect of observation group was higher than that of the control group (P < 0.05). Conclusion Valsartan and cordyceps preparation combined using can reduce the proteinuria levels of type 2 diabetic nephropathy.
[Key words] Diabetic nephropathy； Valsartan； Cordyceps preparation； Effect analysis
糖尿病肾病(DN)是糖尿病引起的微血管病变常见的并发症之一，高血糖和遗传易感性是其危险因素。主要表现为蛋白尿和肾小球滤过率降低，其中血管紧张素Ⅱ起主要作用[1]。严重时常导致肾功能衰竭，出现尿毒症 ......
您现在查看是摘要介绍页，详见PDF附件(1886kb)。